Page 146 - 《中国药房》2026年9期

[ 2 ] BARBETTI F，DEEB A，SUZUKI S. Neonatal diabetes （2）：251-258.
mellitus around the world：update 2024[J]. J Diabetes In‐ [15] GALDERISI A，KERMORVANT-DUCHEMIN E，DARUICH
vestig，2024，15（12）：1711-1724. A，et al. Early treatment of neonatal diabetes with oral
[ 3 ] GREELEY S A W，POLAK M，NJØLSTAD P R，et al. glibenclamide in an extremely preterm infant[J]. JIMD
ISPAD clinical practice consensus guidelines 2022：the Rep，2023，64（2）：161-166.
diagnosis and management of monogenic diabetes in chil‐ [16] KYLAT R I，SENGUTTUVAN R，BADER M Y. Personali-
dren and adolescents[J]. Pediatr Diabetes，2022，23（8）： zed precision medicine in extreme preterm infants with
1188-1211. transient neonatal diabetes mellitus[J]. J Pediatr Endocri‐
[ 4 ] PIPATPOLKAI T，USHER S，STANSFELD P J，et al. nol Metab，2017，30（5）：593-596.
New insights into KATP channel gene mutations and neonatal [17] DE MEDEIROS ABREU G，BASTOS DE SOUZA R，
diabetes mellitus[J]. Nat Rev Endocrinol，2020，16（7）： BERNARDO M C，et al. Case report：when genetic diag‐
378-393. nosis comes late：lessons from a DEND syndrome patient
[ 5 ] FLANAGAN S E，EDGHILL E L，GLOYN A L，et al. successfully transitioned to sulfonylurea[J]. Front Clin
Mutations in KCNJ11，which encodes Kir6.2，are a com‐ Diabetes Healthc，2025，6：1654037.
mon cause of diabetes diagnosed in the first 6 months of [18] HASHIMOTO Y，DATEKI S，HIROSE M，et al. Molecu‐
life，with the phenotype determined by genotype[J]. Diabe‐ lar and clinical features of KATP-channel neonatal diabetes
tologia，2006，49（6）：1190-1197. mellitus in Japan[J]. Pediatr Diabetes，2017，18（7）：532-539.
[ 6 ] CARMODY D，PASTORE A N，LANDMEIER K A，et al. [19] BABY N，VINAYAN K P，PAVITHRAN P，et al. Long-
Patients with KCNJ11-related diabetes frequently have term seizure and neurodevelopmental outcomes of three
neuropsychological impairments compared with sibling children with developmental delay，epilepsy，and neonatal
controls[J]. Diabet Med，2016，33（10）：1380-1386. diabetes （DEND） syndrome after early initiation of sul‐
[ 7 ] EUROPEAN MEDICINES AGENCY. Amglidia （gliben‐ phonylurea[J]. Ann Indian Acad Neurol，2025，28（5）：
clamide oral suspension）：EU summary of product charac‐ 725-728.
teristics[EB/OL].（2018-05-24）[2026-02-20]. https：//www. [20] National Library of Medicine. Impact of sulphonylureas on
ema.europa.eu/en/medicines/human/EPAR/amglidia. neurodevelopmental outcomes in KCNJ11-related iDEND
[ 8 ] 中华医学会儿科学分会内分泌遗传代谢学组. 儿童单基 syndrome[EB/OL].[2026-03-31]. https：//clinicaltrials.gov/
因糖尿病临床诊断与治疗专家共识[J]. 中华儿科杂志， ct2/show/NCT05751525.
2019，57（7）：508-514. [21] BOWMAN P，SHEPHERD M H，FLANAGAN S E，et al.
[ 9 ] PEARSON E R，FLECHTNER I，NJØLSTAD P R，et al. Improved neurodevelopment following in utero sulfonyl‐
Switching from insulin to oral sulfonylureas in patients urea exposure in a patient with KCNJ11 permanent neona‐
with diabetes due to Kir6.2 mutations[J]. N Engl J Med， tal diabetes：future implications for targeted treatment
2006，355（5）：467-477. during pregnancy[J]. Diabetes Care，2025，48（2）：e10-e12.
[10] BOWMAN P，SULEN Å，BARBETTI F，et al. Effective‐ [22] LANNING M S，CARMODY D，SZCZERBIŃSKI Ł，
ness and safety of long-term treatment with sulfonylureas et al. Hypoglycemia in sulfonylurea-treated KCNJ11-neo‐
in patients with neonatal diabetes due to KCNJ11 muta‐ natal diabetes：mild-moderate symptomatic episodes occur
tions：an international cohort study[J]. Lancet Diabetes En‐ infrequently but none involving unconsciousness or
docrinol，2018，6（8）：637-646. seizures[J]. Pediatr Diabetes，2018，19（3）：393-397.
[11] BOWMAN P，MATHEWS F，BARBETTI F，et al. Long- [23] NGOC C T B，DIEN T M，DE FRANCO E，et al. Molecu‐
term follow-up of glycemic and neurological outcomes in lar genetics，clinical characteristics，and treatment out‐
an international series of patients with sulfonylurea- comes of KATP-channel neonatal diabetes mellitus in
treated ABCC8 permanent neonatal diabetes[J]. Diabetes Vietnam National Children’s Hospital[J]. Front Endocri‐
Care，2021，44（1）：35-42. nol，2021，12：727083.
[12] BEN RHAIEM I，BELTRAND J，VERMILLAC G，et al. [24] LINDHOLM OLINDER A，DEABREU M，GREENE S，
Safety and effectiveness of oral glyburide suspension in et al. ISPAD Clinical practice consensus guidelines 2022：
neonatal diabetes mellitus：French retrospective cohort diabetes education in children and adolescents[J]. Pediatr
study[J]. J Endocr Soc，2025，9（7）：bvaf083. Diabetes，2022，23（8）：1229-1242.
[13] KUMAR R，DAYAL D，GEORGE A，et al. Neonatal dia‐ [25] DE FRANCO E，FLANAGAN S E，AL HOUGHTON J，
betes：20-year experience from a tertiary care pediatric dia‐ et al. The effect of early，comprehensive genomic testing
betes clinic in north India[J]. Horm Res Paediatr，2025： on clinical care in neonatal diabetes：an international co‐
1-12. hort study[J]. Lancet，2015，386（9997）：957-963.
[14] LI X Z，XU A J，SHENG H Y，et al. Early transition from （收稿日期：2026-01-22 修回日期：2026-03-31）
insulin to sulfonylureas in neonatal diabetes and follow- （编辑：唐晓莲）
up：experience from China[J]. Pediatr Diabetes，2018，19

· 1240 · China Pharmacy 2026 Vol. 37 No. 9 中国药房 2026年第37卷第9期